...
首页> 外文期刊>Therapeutic advances in urology. >Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial
【24h】

Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial

机译:工作人员对大剂量抗毒蕈碱疗法的治疗依从性:一项随机试验

获取原文
           

摘要

The aim of this work was to study the factors affecting the stability of working patients in antimuscarinic (AM) drug treatment. The prevalence of urge urinary incontinence (UUI) is an average of between 8.2% and 16.0% of the population. UUI is a condition that adversely affects the health-related quality of life. The first-line therapy in managing UUI is AM treatment. In 1006 patients between 18 and 60 years old (627 women, 379 men, mean age 69.4) who received AM treatment for one year, the possible demographic, socioeconomic and health factors influencing compliance were studied. Also, the functional state of the lower urinary tract (LUT) was studied in this randomized, prospective survey. The study instruments were the documents of employers, tax offices, outpatient records, OABq-SF (overactive bladder - short form) questionnaires, MOS SF-36 (Medical Outcomes Study short form-36), voiding charts, and uroflowmetry data. The compliance to AM treatment within 6 months was retained in 49.5% patients; during the year, in 32.3% of patients. The average time for reaching the 30-day break in taking trospium was 194 days. In the course of the experiment it was revealed that compliance to AM treatment was significantly higher in patients taking solifenacin and trospium in high dosages (p ? 0.01, p ? 0.05), suffering from severe symptoms of urgency (p ? 0.01), and having a low level of side effects (p ? 0.01). A satisfactory level of compliance is characteristic of patients with a high level of monthly and annual income (p ? 0.01, p ? 0.01), a low percentage of expenses to AM (p ? 0.05), and rarely changing employers (p ? 0.05). In addition, the compliance to treatment is higher in older adults (p ? 0.05), living in the urban district (p ? 0.01), and working in educational (p ? 0.05) and health (p ? 0.01) institutions, having a high level of the indices of Social Functioning (p ? 0.05), Role-Emotional (p ? 0.05), and Mental Health (p ? 0.01). As a result of this study, under the control of the objective functional state of LUT, the influence of various factors on the patients’ stability in the treatment with AM drugs was revealed.
机译:这项工作的目的是研究影响抗毒蕈碱(AM)药物治疗中在职患者稳定性的因素。尿急尿失禁(UUI)的患病率平均为人口的8.2%至16.0%。 UUI是对健康相关的生活质量产生不利影响的疾病。管理UUI的一线治疗是AM治疗。在接受AM治疗一年的1006名18至60岁的患者(627名女性,379名男性,平均年龄69.4)中,研究了可能影响依从性的人口统计学,社会经济因素和健康因素。此外,在这项随机的前瞻性调查中还研究了下尿路(LUT)的功能状态。研究工具包括雇主,税务局,门诊记录,OABq-SF(膀胱过动症-简短形式)问卷,MOS SF-36(医学成果研究简短形式-36),排尿图和尿流测量数据。 49.5%的患者保留了6个月内AM治疗的依从性;年中,有32.3%的患者。达到30天休息时间的平均时间为194天。在实验过程中,发现服用高剂量索非那新和托吡铵(p <0.01,p <0.05),患有严重尿急症状(p <0.01),并有严重症状的患者对AM治疗的依从性明显更高。副作用低(p≤0.01)。令人满意的依从性水平是患者的特征,这些患者的月收入和年收入水平较高(p = 0.01,p = 0.01),AM支出的比例较低(p = 0.05),并且很少更换雇主(p = 0.05) 。此外,老年人(p = 0.05),居住在市区(p = 0.01)以及在教育机构(p = 0.05)和卫生机构(p = 0.01)工作的人对医疗的依从性较高,他们的健康水平较高。社会功能指数(P <0.05),角色情感(P <0.05)和心理健康(P <0.01)的水平。这项研究的结果是,在LUT的客观功能状态的控制下,揭示了各种因素对AM药物治疗患者稳定性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号